Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 26208-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- CENPK antibody
- Antibody type
- Polyclonal
- Description
- CENPK antibody (Cat. #26208-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references m(6)A demethylase ALKBH5 maintains stemness of intrahepatic cholangiocarcinoma by sustaining BUB1B expression and cell proliferation.
The inhibition of centromere protein K causes anticancer effects in breast carcinoma via effects on the FAK/PI3K/AKT/mTOR pathway.
Bioinformatics analysis combined with experiments predicts CENPK as a potential prognostic factor for lung adenocarcinoma.
Overexpression of centromere protein K (CENPK) gene in Differentiated Thyroid Carcinoma promote cell Proliferation and Migration.
Downregulation of CENPK suppresses hepatocellular carcinoma malignant progression through regulating YAP1.
Gao Y, Yu M, Liu Z, Liu Y, Kong Z, Zhu C, Qin X, Li Y, Tang L
Translational oncology 2024 Mar;41:101858
Translational oncology 2024 Mar;41:101858
The inhibition of centromere protein K causes anticancer effects in breast carcinoma via effects on the FAK/PI3K/AKT/mTOR pathway.
Yu J, Wang K, Yang S, Li G
Toxicology and applied pharmacology 2022 Nov 1;454:116232
Toxicology and applied pharmacology 2022 Nov 1;454:116232
Bioinformatics analysis combined with experiments predicts CENPK as a potential prognostic factor for lung adenocarcinoma.
Ma J, Chen X, Lin M, Wang Z, Wu Y, Li J
Cancer cell international 2021 Jan 21;21(1):65
Cancer cell international 2021 Jan 21;21(1):65
Overexpression of centromere protein K (CENPK) gene in Differentiated Thyroid Carcinoma promote cell Proliferation and Migration.
Li Q, Liang J, Zhang S, An N, Xu L, Ye C
Bioengineered 2021 Dec;12(1):1299-1310
Bioengineered 2021 Dec;12(1):1299-1310
Downregulation of CENPK suppresses hepatocellular carcinoma malignant progression through regulating YAP1.
Wang J, Li H, Xia C, Yang X, Dai B, Tao K, Dou K
OncoTargets and therapy 2019;12:869-882
OncoTargets and therapy 2019;12:869-882
No comments: Submit comment
No validations: Submit validation data